Ulta Beauty, Inc. — Form 10-Q Summary
Period clarification: The supplied filing is for the 13 and 26 weeks ended July 30, 2022 (fiscal 2022 second quarter), not 2021 Q2 as indicated in the request metadata. Comparisons below are with the periods ended July 31, 2021. Amounts are in millions unless stated otherwise.
Business context and reporting period
Ulta Beauty operates beauty retail stores, e-commerce and salons. It reported one operating segment and 1,325 stores across 50 states at July 30, 2022. Results are seasonal, with significant sales and profits typically occurring in the holiday-season fourth quarter.
Financial performance and liquidity
| Metric | 13 weeks ended July 30, 2022 | 26 weeks ended July 30, 2022 |
|---|---|---|
| Net sales | $2,297.1; +16.8% year over year | $4,643.0; +18.9% |
| Gross profit / margin | $928.2 / 40.4% (40.6% prior year) | $1,869.2 / 40.3% (39.7%) |
| Operating income / margin | $391.4 / 17.0% (16.9%) | $829.1 / 17.9% (16.3%) |
| Net income / margin | $295.7 / 12.9% (12.8%) | $627.1 / 13.5% (12.3%) |
| Diluted EPS | $5.70 (prior year $4.56) | $12.00 (prior year $8.66) |
| Comparable sales | +14.4% (prior year +56.3%) | +16.2% (prior year +60.9%) |
Second-quarter comparable sales reflected transactions up 8.3% and average ticket up 5.6%. For the first half, transactions rose 9.2% and average ticket 6.4%.
For the first half, operating cash flow was $540.7, compared with $401.4 a year earlier. Capital expenditures were $120.5, versus $57.3; cash used in financing was $416.3, including $434.4 of common-share repurchases. Cash and equivalents were $434.2 at quarter-end, versus $770.1 a year earlier and $431.6 at fiscal year-end.
Current assets were $2,442.9 and current liabilities $1,502.1. The company had no borrowings under its revolving credit facility and reported compliance with its covenants. Operating lease liabilities totaled $1,856.7, including current and non-current portions. Merchandise inventory was $1,666.1, up $222.4, or 15.4%, year over year.
Changes and management commentary
- Sales growth was attributed to beauty-category resilience, new brands and product innovation, and easing COVID-19 restrictions. Other revenue increased $19.0 in the quarter and $39.4 for the first half versus the comparable prior-year periods.
- Quarterly gross margin edged down as lower merchandise margin and higher inventory shrink more than offset fixed-cost leverage and stronger other revenue. First-half gross margin improved on fixed-cost leverage, other revenue growth and favorable channel mix, partly offset by merchandise margin and shrink.
- SG&A increased in dollars but declined as a percentage of sales: 23.3% versus 23.6% for the quarter and 22.3% versus 23.3% for the first half. Management cited lower marketing costs and store-cost leverage, partly offset by strategic investment and corporate overhead.
- Inventory growth reflected new stores, key brand launches, higher inventory costs and receipts to maintain in-stock levels. The company opened 17 stores and relocated 10 during the first half.
- In March 2022, the board authorized a new $2.0 billion repurchase program, replacing the prior authorization. The company repurchased $434.4 of shares in the first half; $1.6 billion remained available at July 30.
Outlook, risks and contingencies
The filing provides no specific numerical full-year guidance. Management said it expects its cash sources to meet short- and long-term requirements and described long-term growth priorities that include comparable-sales growth, omnichannel development and expansion toward a 1,500–1,700-store U.S. chain. Management cautioned that interim results may not indicate full-year performance.
Risks highlighted include changing consumer spending and economic conditions; inflation in payroll, benefits, supply-chain and other costs; COVID-19 effects; competition and changing beauty preferences; execution of growth, technology and supply-chain initiatives; and cybersecurity, privacy and system disruptions. Management stated inflation had not materially affected results to date but could pressure spending, sales and margins. Legal proceedings were described as incidental, with no expected material adverse effect; no material changes to previously disclosed risk factors were reported.
Important facts for investors to verify
- Confirm the requested period: this filing reports fiscal 2022 Q2, ended July 30, 2022.
- Assess whether sales and comparable-sales growth can persist after the unusually high prior-year comparison base.
- Monitor merchandise margin, inventory shrink, inventory levels and inflation-related cost pressures.
- Review cash conversion alongside elevated capital expenditures, share repurchases and lease obligations.
- Check subsequent filings for updated guidance, repurchase activity, and developments in the cited operational and macroeconomic risks.